XWELL (NASDAQ:XWEL) Announces Earnings Results, Misses Expectations By $0.51 EPS

XWELL (NASDAQ:XWEL) released its quarterly earnings results on Wednesday. The company reported ($1.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51), Zacks reports. XWELL had a negative net margin of 58.17% and a negative return on equity of 352.37%.

XWELL Stock Performance

Shares of XWEL opened at $1.46 on Thursday. XWELL has a twelve month low of $0.26 and a twelve month high of $2.20. The company has a market cap of $11.58 million, a P/E ratio of -0.29 and a beta of 1.01. The company’s fifty day simple moving average is $1.28 and its 200-day simple moving average is $0.88.

Analyst Upgrades and Downgrades

XWEL has been the topic of a number of recent research reports. Weiss Ratings downgraded shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.